Trial Profile
Study of correlation between prognostic value of cell frequencies and progression free survival, in melanoma patients treated with ipilimumab
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Pharmacodynamics; Therapeutic Use
- 10 Aug 2015 New trial record